Abstract
Current interest in glycolipid-based drugs started with work by a Japanese beer company. In the early 1990s, chemists at Kirin Brewery isolated a family of glycolipid natural products called agelas...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
